CPS Research by FutureMeds

Did you know that 1 in 7 people suffer from migraines? This research study hopes to help those who experience migraines. This study is assessing the impact a new investigational preventative migraine treatment has on the number of migraines experienced in a typical month. You will receive compensation for your travel & inconvenience whilst in this study. Constant migraines affecting your life? Lets work together to help shape the future of migraine care. https://lnkd.in/exPMyFKa

The CPS Research clinic is now closed for Christmas 🎄 We have a very exciting year coming up in 2024 and our clinic will, of course, be open between Christmas and New Year but until then, have a wonderful Christmas! 

CPS Research is now part of FutureMeds, Europe’s 1st Dedicated DCT Site Network. “Today marks a significant milestone for CPS & FutureMeds as we bring together our wealth of experience to the ultimate benefit of our clients and patients.” Commented Craig McCallum, General Manager at CPS Research As part of FutureMeds, our experienced site team, with over 250 trials under their belt, will continue to build relationships with local communities, amplify the site’s impact in driving medical progress and improve patients' access to new treatments. "Having developed CPS Research with Alan, we are delighted to see it become part of the growing FutureMeds Site Network. By contributing to medical progress, we are sure CPS Research's team will build on our legacy and continue to thrive as one of the best dedicated research centres in the UK." Added Dr Gordon Crawford BSC MBCHB MRCGP, co-founder of CPS Research “CPS Research has a reputable standing in the industry, boasting over three decades of expertise overseeing and conducting clinical trials. We are thrilled to welcome their knowledgeable team into our fold.” Commented John Allen, Managing Director at FutureMeds UK For more information, please read on: https://lnkd.in/emJvurAg #ClinicalTrails #ClinicalResearch